Skip to main content
Equibles
GMAB logo

GMAB · Genmab A/S

Track GMAB — free

Use GMAB with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about GMAB

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$31.94 +0.60 (+1.91%) At close · Aug 14
Market Cap
$19.63B
Shares
614.62M

Genmab A/S Earnings Call Transcripts

Every quarterly earnings call for Genmab A/S (GMAB) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-06
Earnings conference call (announced in 6-K)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Earnings conference call (announced in 6-K)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-11
Barclays 28th Annual Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2025-12-31
Genmab A/S Q4 FY2025 Earnings Call
Confident tone EPKINLY commercial performance and pipeline expansion Petosemtamab (Merus acquisition) late-stage catalysts TIVDAK global commercial launches
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Genmab A/S Q3 FY2025 Earnings Call
Confident tone Rina-S late-stage development EPKINLY (epcoritamab) commercial and clinical progress Merus acquisition / petosemtamab
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Genmab A/S Q2 FY2025 Earnings Call
Confident tone Rina-S pipeline expansion Epcoritamab/EPKINLY in follicular lymphoma Financial performance and capital allocation
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Genmab A/S Q1 FY2025 Earnings Call
Confident tone Rina-S pipeline progress and data EPKINLY commercial performance and expansion Proprietary late-stage pipeline focus
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Genmab A/S Q4 FY2024 Earnings Call
Confident tone EPKINLY GEN1042 / INI opportunity Rina-S
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Genmab A/S Q3 FY2024 Earnings Call
Confident tone Wholly-owned late-stage assets EPKINLY commercial performance EPKINLY pipeline expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Genmab A/S Q2 FY2024 Earnings Call
Confident tone acasunlimab development EPKINLY / epcoritamab commercial launch ProfoundBio acquisition / Rina-S
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Genmab A/S Q1 FY2024 Earnings Call
Confident tone Epcoritamab/EPKINLY regulatory progress and launch ProfoundBio acquisition and Rina-S ADC pipeline TIVDAK cervical cancer and head & neck expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Genmab A/S Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Genmab A/S Q3 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Genmab A/S Q2 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Genmab A/S Q1 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Genmab A/S Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Genmab A/S Q3 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Genmab A/S Q2 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Genmab A/S Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Genmab A/S Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Genmab A/S Q3 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Genmab A/S Q2 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Genmab A/S Q1 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Genmab A/S Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Genmab A/S Q3 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Genmab A/S Q2 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Genmab A/S Q1 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–27 of 27 earnings calls
Key facts CIK 1434265 CUSIP 372303206 13F (30d) 290 filings 264 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)